Value of Digital Breast Tomosynthesis in Breast Lesions
Added Value of Digital Breast Tomosynthesis in Characterization of Breast Lesions
1 other identifier
interventional
50
1 country
1
Brief Summary
The aim of the study is to evaluate the added value of digital breast tomosynthesis (DBT) in the characterization of breast lesions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 9, 2024
CompletedFirst Submitted
Initial submission to the registry
November 11, 2024
CompletedFirst Posted
Study publicly available on registry
November 14, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 6, 2025
CompletedNovember 14, 2024
November 1, 2024
11 months
November 11, 2024
November 12, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Compare DBT with traditional mammography in terms of diagnostic accuracy, sensitivity, and specificity for detecting and differentiating benign and malignant breast lesions
1 hour
Study Arms (1)
Patients with breast lesions
EXPERIMENTALInterventions
In digital breast tomosynthesis (DBT), images are acquired using a specialized X-ray tube that moves in an arc around the breast. This technique captures multiple low-dose images from various angles, typically within a 15° to 60° range. These images are then reconstructed into 1-mm slices to create a 3D representation of the breast, allowing for detailed layer-by-layer evaluation. The number of images acquired varies depending on the size of the breast and the specifications of the equipment but generally ranges from 10 to 25 projections, captured within a few seconds.
Eligibility Criteria
You may qualify if:
- Patients with mammographic breast lesions of BIRADS III, IV.
- Dense breast in patients with complaints (BIRADS 0) which needed further assessment.
You may not qualify if:
- Pregnant females to avoid the hazards of ionizing radiation to the fetus.
- Patients with known metastatic breast cancer.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag University
Sohag, 82749, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.B.B.Ch
Study Record Dates
First Submitted
November 11, 2024
First Posted
November 14, 2024
Study Start
October 9, 2024
Primary Completion
September 10, 2025
Study Completion
December 6, 2025
Last Updated
November 14, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share
for risk of participant data identification and for privacy concerns